FDA wants oncology sponsors to get a clearer picture of the safety, tolerability and efficacy of multiple doses earlier in development. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
